Carsten Patrick Marcus

Dr. Carsten Patrick Marcus


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AKANne Kuebart
ANne Kuebart
KGKatharina Gross
Katharina Gross
JRJan-Joschua Ripkens
Jan-Joschua Ripkens
TTTheresa Tenge
Theresa Tenge
ARAnnika Raupach
Annika Raupach
AHAnna Herminghaus
Anna Herminghaus
Microcirculatory and mitochondrial dysfunction are considered the main mechanisms of septic shock. Studies suggest that statins modulate inflammatory response, microcirculation, and mitochondrial function, possibly through their action on peroxisome proliferator-activated receptor alpha (PPAR-α). The aim of this study was to examine the effects of pravastatin on microcirculation and mitochondrial function in the liver and colon and the role of PPAR-α under septic conditions. This study was performed with the approval of the local animal care and use committee. Forty Wistar rats were randomly divided into 4 groups: sepsis (colon ascendens stent peritonitis, CASP) without treatment as control, sepsis + pravastatin, sepsis + PPAR-α-blocker GW6471, and sepsis + pravastatin + GW6471. Pravastatin (200 µg/kg s.c.) and GW6471 (1 mg/kg) were applied 18 h before CASP-operation. 24 h after initial surgery, a relaparotomy was performed, followed by a 90 min observation period for assessment of microcirculatory oxygenation (μHbO2) of the liver and colon. At the end of the experiments, animals were euthanized, and the colon and liver were harvested. Mitochondrial function was measured in tissue homogenates using oximetry. The ADP/O ratio and respiratory control index (RCI) for complexes I and II were calculated. Reactive oxygen species (ROS) production was assessed using the malondialdehyde (MDA)-Assay. Statistics: two-way analysis of variance (ANOVA) + Tukey’s/Dunnett’s post hoc test for microcirculatory data, Kruskal–Wallis test + Dunn’s post hoc test for all other data. In control septic animals µHbO2 in liver and colon deteriorated over time (µHbO2: −9.8 ± 7.5%* and −7.6 ± 3.3%* vs. baseline, respectively), whereas after pravastatin and pravastatin + GW6471 treatment μHbO2 remained constant (liver: µHbO2 pravastatin: −4.21 ± 11.7%, pravastatin + GW6471: −0.08 ± 10.3%; colon: µHbO2 pravastatin: −0.13 ± 7.6%, pravastatin + GW6471: −3.00 ± 11.24%). In both organs, RCI and ADP/O were similar across all groups. The MDA concentration remained unchanged in all groups. Therefore, we conclude that under septic conditions pravastatin improves microcirculation in the colon and liver, and this seems independent of PPAR-α and without affecting mitochondrial function.

Verified
Journal Article
Open access
PDF file
CMCarsten Patrick Marcus
Carsten Patrick Marcus
CHClaudia Hansen
Claudia Hansen
CSCharlotte Schlimgen
Charlotte Schlimgen
JEJeanne Eitner-Pchalek
Jeanne Eitner-Pchalek
JSJan Schulz
Jan Schulz
AHAnna Herminghaus
Anna Herminghaus
Systemic vasodilating agents like nitroglycerin (NG) or iloprost (Ilo) show beneficial effects on intestinal microcirculation during sepsis, which could be attenuated by activation of the sympathetic nervous system or systemic side effects of vasodilating agents. This exploratory study aimed to investigate the effects of topically administered vasodilators and the parasympathetic drug carbachol on colonic microcirculatory oxygenation (µHbO2), blood flow (µFlow) and mitochondrial respiration. A total of 120 male Wistar rats were randomly assigned to twelve groups and underwent either colon ascendens stent peritonitis (CASP) or sham surgery. After 24 h, animals received the following therapeutic regimes: (1) balanced full electrolyte solution, (2) carbachol, (3) NG, (4) Ilo, (5) NG + carbachol, and (6) Ilo + carbachol. Mitochondrial respiration was measured in colon homogenates by respirometry. In sham animals, NG (−13.1%*) and Ilo (−10.5%*) led to a decrease in µHbO2. Additional application of carbachol abolished this effect (NG + carbachol: −4.0%, non-significant; Ilo + carbachol: −1.4%, non-significant). In sepsis, carbachol reduced µHbO2 when applied alone (−10.5%*) or in combination with NG (−17.6%*). Thus, the direction and degree of this effect depend on the initial pathophysiologic condition.

25 November 2025 in Shock
Verified
Journal Article
Open access
CMCarsten Patrick Marcus
Carsten Patrick Marcus
SHStefan Hof
Stefan Hof
PTPhilisa Thelen
Philisa Thelen
AGAlena Gesing
Alena Gesing
AVAntonia Vocke
Antonia Vocke
AHAnna Herminghaus
Anna Herminghaus
Background: Sepsis is characterized by systemic inflammation and microcirculatory dysfunction, contributing to multiorgan failure. In the gastrointestinal tract, impaired microcirculation and mitochondrial dysfunction promote barrier failure and bacterial translocation. While dobutamine is commonly used to augment cardiac output in septic shock, its direct effects on intestinal microcirculation and mitochondrial respiration remain unclear. The microcirculatory impact of adjunctive low-dose vasopressin is similarly uncertain. Methods: Twenty-four hours after colon ascendens stent peritonitis or sham surgery, 88 male Wistar rats were randomized to receive vehicle, vasopressin, dobutamine, or their combination under septic or sham conditions. Colonic and hepatic microcirculatory oxygenation (µHbO 2 ) and microvascular blood flow (µFlow) were measured for 90 minutes using tissue-reflectance spectrophotometry and laser Doppler flowmetry. Mitochondrial respiration was assessed in colon and liver homogenates of septic animals by high-resolution respirometry. Microcirculatory data were analyzed using mixed-effects models with Tukey’s and Dunnett’s post hoc tests. Mitochondrial data were analyzed using the Kruskal–Wallis test. A two-sided P < 0.05 was considered statistically significant. Results: In septic rats, dobutamine significantly improved colonic microvascular oxygenation (∆µHbO 2 10.2% ± 13.4% vs. −2.3% ± 4.4% in controls and vs. baseline, P < 0.05) and microvascular blood flow (∆µFlow 30 ± 20 arbitrary units vs. baseline, P < 0.05). Combined dobutamine and vasopressin increased microvascular blood flow (∆µFlow 28 ± 27 arbitrary units vs. baseline, P < 0.05) but did not improve tissue oxygenation. Hepatic microcirculation and mitochondrial respiration remained largely unaltered. Conclusions: Dobutamine improves colonic microcirculation in sepsis, whereas concomitant vasopressin attenuates its oxygenation effects.

Verified
Journal Article
Open access
PDF file
AKANne Kuebart
ANne Kuebart
KGKatharina Gross
Katharina Gross
CMCharlotte Maicher
Charlotte Maicher
MSMax Sonnenschein
Max Sonnenschein
ARAnnika Raupach
Annika Raupach
AHAnna Herminghaus
Anna Herminghaus
Recent studies observed, despite an anti-hyperlipidaemic effect, a positive impact of fibrates on septic conditions. This study evaluates the effects of gemfibrozil on microcirculatory variables, mitochondrial function, and lipid peroxidation levels with regard to its potential role as an indicator for oxidative stress in the colon and liver under control and septic conditions and dependencies on PPARα-mediated mechanisms of action. With the approval of the local ethics committee, 120 Wistar rats were randomly divided into 12 groups. Sham and septic animals were treated with a vehicle, gemfibrozil (30 and 100 mg/kg BW), GW 6471 (1 mg/kg BW, PPARα inhibitor), or a combination of both drugs. Sepsis was induced via the colon ascendens stent peritonitis (CASP) model. Then, 24 h post sham or CASP surgery, a re-laparotomy was performed. Measures of vital parameters (heart rate (HR), mean arterial pressure (MAP), and microcirculation (µHbO2)) were recorded for 90 min. Mitochondrial respirometry and assessment of lipid peroxidation via a malondialdehyde (MDA) assay were performed on colon and liver tissues. In the untreated sham animals, microcirculation remained stable, while pre-treatment with gemfibrozil showed significant decreases in the microcirculatory oxygenation of the colon. In the CASP animals, µHbO2 levels in the colon and the liver were significantly decreased 90 min after laparotomy. Pre-treatment with gemfibrozil prevented the microcirculatory aberrations in both organs. Gemfibrozil did not affect mitochondrial function and lipid peroxidation levels in the sham or CASP animals. Gemfibrozil treatment influences microcirculation depending on the underlying condition. Gemfibrozil prevents sepsis-induced microcirculatory aberrances in the colon and liver PPARα-independently. In non-septic animals, gemfibrozil impairs the microcirculatory variables in the colon without affecting those in the liver.

6 March 2026 in Intensive Care Medicine Experimental
Verified
Journal Article
Open access
CMCarsten Patrick Marcus
Carsten Patrick Marcus
SHStefan Hof
Stefan Hof
AGAlena Gesing
Alena Gesing
PTPhilisa Thelen
Philisa Thelen
SOSarah Orzol
Sarah Orzol
AHAnna Herminghaus
Anna Herminghaus
Background: Microcirculatory dysfunction is a key pathophysiological feature of sepsis and contributes to organ failure and mortality. In the gastrointestinal tract, impaired barrier function due to microcirculatory injury promotes translocation of inflammatory mediators and bacteria, worsening systemic inflammation and multiorgan dysfunction. Inotropic and vasoactive agents may improve microvascular perfusion through vasodilation in addition to their inotropic effects. Milrinone, a phosphodiesterase-3 inhibitor, and levosimendan, a calcium sensitizer, have shown promising but inconsistent effects in sepsis, while data on their direct microcirculatory and mitochondrial effects in abdominal organs remain limited. Sub-therapeutic vasopressin has demonstrated beneficial effects on gut microcirculation in experimental models, but its combination with inotropes has not been investigated. We hypothesized that (1) milrinone and levosimendan increase colonic and hepatic microvascular blood flow and oxygenation, (2) adjunctive low-dose vasopressin further enhances gastrointestinal microcirculation, and (3) mitochondrial respiration does not differ between treatment groups. Methods: Male Wistar rats ( n = 105) underwent colon ascendens stent peritonitis (CASP) or sham surgery to induce moderate sepsis. Twenty-four hours later, animals received intravenous infusions of vehicle, milrinone, levosimendan, or the respective inotrope with low-dose vasopressin. Colonic and hepatic microvascular oxygenation and blood flow were assessed using tissue-reflectance spectrophotometry and laser Doppler flowmetry. Mitochondrial respiration in colonic and hepatic tissue homogenates from septic animals was analyzed by respirometry. Statistical analyses included mixed-effects models with Tukey or Dunnett post-hoc tests and Kruskal–Wallis tests with Dunn’s correction, using a two-sided significance level of α = 0.05. Results: In septic animals, milrinone and levosimendan increased colonic and hepatic microvascular blood flow. With adjunctive vasopressin, colonic perfusion remained increased, whereas hepatic blood flow did not increase. Microvascular oxygenation remained unchanged in both organs. In sham-operated animals, microvascular blood flow and oxygenation did not differ between treatment groups. Mitochondrial respiration in colon and liver was unchanged across treatments, as indicated by respiratory control index and ADP/O ratio. Conclusions: In experimental abdominal sepsis, milrinone and levosimendan increase colonic and hepatic microvascular blood flow without affecting mitochondrial respiration. Adjunctive vasopressin alters hepatic but not colonic microvascular responses during combined inotropic therapy.

15 April 2026 in Journal of Clinical Monitoring and Computing
Verified
Journal Article
Open access
PDF file
SRSophia Riesemann
Sophia Riesemann
LWLuca J. Wachtendorf
Luca J. Wachtendorf
BBBen L. P. Braeuer
Ben L. P. Braeuer
Sebastian D SahliSebastian D Sahli
Sebastian D Sahli
BPBéla-Simon Paschold
Béla-Simon Paschold
MRMark J. Robitaille
Mark J. Robitaille
The respiratory exchange ratio (RER), defined as the ratio of carbon dioxide (CO2) production to oxygen (O2) consumption, may be a non-invasive and continuously measurable alternative to lactate for identifying patients at risk of postoperative complications that has been examined in non-cardiac surgery. We investigated whether intraoperative RER predicts blood lactate levels and postoperative complications in cardiac surgery. This retrospective cohort study included adult patients undergoing cardiac surgery with cardiopulmonary bypass at Beth Israel Deaconess Medical Center in Boston, USA, between 2008 and 2020. Intraoperative minute-by-minute data of inspired and expired fractions of CO2 and O2 were analyzed. Univariable and a priori-defined multivariable logistic regression models were used to evaluate the association between the median RER during surgery, intraoperative lactate and 7-day major postoperative complications (European Perioperative Clinical Outcome Definitions). 324,646 RER calculations of 4,058 patients were included. 1,745 (43.0%) patients experienced 7-day postoperative complications. The median (IQR) RER was 0.64 (0.48–0.92) before and 0.65 (0.48–0.97) after bypass. The RER within 10 min prior to lactate testing was associated with lactate levels > 2 mmol/l (adjusted odds ratio [ORadj] 1.11, 95% confidence interval [CI] 1.01–1.23, p = 0.031). Neither RER before nor after bypass was associated with 7-day postoperative complications (before bypass: ORadj 1.02, 95%CI 0.95–1.10, p = 0.55; after bypass: ORadj 1.03, 95%CI 0.95–1.13, p = 0.46). While RER showed a modest relationship with hyperlactatemia, its utility as a predictor of postoperative complications appears limited in real-world data. Further research is needed to clarify its role and potential for clinical applicability.